Zanamivir, a potent neuraminidase inhibitor, remains a frontline defense in the global management of influenza. Marketed under the brand name Relenza, its role extends from seasonal outbreak control to national pandemic stockpiles. Following heightened global health awareness, the market is experiencing a strategic reassessment, projected to grow from USD 342.4 million in 2024 to USD 484.8...

Executive Summary Hepatic Antiviral Drugs Market : Hepatic antiviral drugs market size was valued at USD 18.43 billion in 2024 and is projected to reach USD 26.37 billion by 2032, with a CAGR of 4.58% during the forecast period of 2025 to 2032. The data and information about  industry are taken from reliable sources such as websites, annual reports of the companies, and journals,...

"Global Demand Outlook for Executive Summary Warts Treatment Market Size and Share The global warts treatment market size was valued at USD 82.88 million in 2024 and is expected to reach USD 109.98 million by 2032, at a CAGR of 3.60% during the forecast period Warts Treatment Market report supports businesses to thrive in the market by providing them with an array...